Skip to content

Role of Exosomes in Ocular Surface Diseases

Role of Exosomes in Ocular Surface Diseases

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027452
Enrollment
Unknown
Registered
2019-11-13
Start date
2019-12-24
Completion date
Unknown
Last updated
2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ocular surface diseases

Interventions

Control group:N/A
Keratitis group:N/A
Corneal graft rejection group:N/A
Blepharitis group:N/A

Sponsors

The First Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with ocular surface diseases, e.g. keratitis, MGD,corneal graft rejection,dry eye; 2. Only one eye of a patient will be eligible for study entry; 3. Patients who are adult males and females who are aged 18 or older, and are considered mentally sound; 4. Patients who have ability and willingness to return for all scheduled visits and assessments; 5. Patients who have signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients who are incapable, either by law or of mental state, of giving consent in their own right; 2. Patients who are pregnant or breastfeeding; 3. Patients with a history of drug allergy; 4. Systemic condition is poor, such as myocardial infarction, cerebrovascular accident, renal failure,cancer and so on,and the researchers assessed those who are unable to complete the trail.

Design outcomes

Primary

MeasureTime frame
Exosome;Evaluation of ocular surface sign/symptoms;

Countries

China

Contacts

Public ContactHong Zhang

The First Affiliated Hospital of Harbin Medical University

13804505456@163.com+86 13804505456

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026